Nolte, Frederick S
Mayo Clinic
Department of Pathology and Laboratory Medicine, Medical University of South Carolinagrid.259828.c, Charleston, South Carolina, USA.
Citations 1
Considerations from the College of American Pathologists for Implementation of an Assay for SARS-CoV-2 Testing after a Change in Regulatory Status
Peaper, David R. , Rhoads, Daniel D. , Sullivan, Kaede V. , Couturier, Marc Roger , Humphries, Romney M. , Nolte, Frederick S. , Rowlinson, Marie‐Claire , She, Rosemary C. , Simner, Patricia J. , Theel, Elitza S. , Wojewoda, Christina , Nolte, Frederick S , Simner, Patricia J , Theel, Elitza S , Wojewoda, Christina M , Humphries, Romney , Rhoads, Daniel D , Martin, Isabella W.
Journal of Clinical Microbiology | July 14, 2021 | Volume: 59 | Issue: 10 | Pages: No page available
The U.S. Food & Drug Administration (FDA) regulates the marketing of manufacturers’ in vitro diagnostic tests (IVDs), including assays for the detection of SARS-CoV-2.